Receipt of Diabetes Specialty Care and Management Services by Older Adults With Diabetes in the U.S., 2015-2019: An Analysis of Medicare Fee-for-Service Claims.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
    • Publication Information:
      Publication: Alexandria Va : American Diabetes Association
      Original Publication: New York, American Diabetes Assn.
    • Subject Terms:
    • Abstract:
      Objective: We characterized the receipt of diabetes specialty care and management services among older adults with diabetes.
      Research Design and Methods: Using a 20% random sample of fee-for-service Medicare beneficiaries aged ≥65 years, we analyzed cohorts of type 1 diabetes (T1D) or type 2 diabetes (T2D) with history of severe hypoglycemia (HoH), and all other T2D annually from 2015 to 2019. Outcomes were receipt of office-based endocrinology care, diabetes education, outpatient diabetes health services, excluding those provided in primary care, and any of the aforementioned services.
      Results: In the T1D cohort, receipt of endocrinology care and any service increased from 25.9% and 29.2% in 2015 to 32.7% and 37.4% in 2019, respectively. In the T2D with HoH cohort, receipt of endocrinology care and any service was 13.9% and 16.4% in 2015, with minimal increases. Age, race/ethnicity, residential setting, and income were associated with receiving care.
      Conclusions: These findings suggest that many older adults may not receive specialty diabetes care and underscore health disparities.
      (© 2024 by the American Diabetes Association.)
    • References:
      Diabetes Care. 2022 Jul 7;45(7):1549-1557. (PMID: 35796766)
      MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1045-9. (PMID: 25412060)
      MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1020-1023. (PMID: 31725705)
      Acad Pediatr. 2024 Jan-Feb;24(1):59-67. (PMID: 37148967)
      Diabetes Care. 2019 Mar;42(3):427-433. (PMID: 30679304)
      Diabetes Res Clin Pract. 2023 Sep;203:110859. (PMID: 37517777)
      Diabetes Care. 2024 Jan 1;47(Suppl 1):S244-S257. (PMID: 38078580)
      Diabetes Technol Ther. 2023 Jun;25(S3):S56-S64. (PMID: 37306446)
      Clin Epidemiol. 2018 Dec 17;11:1-15. (PMID: 30588119)
      Lancet Diabetes Endocrinol. 2020 Oct;8(10):855-867. (PMID: 32946822)
      JAMA. 2019 Apr 2;321(13):1304-1305. (PMID: 30848814)
      J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. (PMID: 30903688)
      Pediatr Diabetes. 2014 Dec;15(8):573-84. (PMID: 24913103)
      MMWR Morb Mortal Wkly Rep. 2019 Nov 01;68(43):961-966. (PMID: 31671084)
      Diabetes Care. 2021 Sep;44(9):2025-2032. (PMID: 34353883)
      Diabetes Care. 2010 Dec;33(12):2573-9. (PMID: 21115767)
    • Grant Information:
      K12 TR004416 United States TR NCATS NIH HHS; K12TR004416 United States TR NCATS NIH HHS
    • Publication Date:
      Date Created: 20240522 Date Completed: 20240620 Latest Revision: 20240629
    • Publication Date:
      20240629
    • Accession Number:
      PMC11208748
    • Accession Number:
      10.2337/dc23-1982
    • Accession Number:
      38776523